Transgenic Group Inc.
Basic information
- Head office
- 2-3-36 Tenjin, Chuo-ku, Fukuoka City
- Chief executive
- Kenji Fukunaga
- Capital
- 50,000,000
- Employees (non-consolidated)
- 6 people
- Employees (consolidated)
- 227 people
- Start date
- 1998-04-21
- End date
Websites
Business
Related companies
Network
History
Founded KUMAMOTO Antibody Research Institute Inc. in Egoshi, Kumamoto City, with capital of 11 million yen, for the development, manufacturing, and sale of antibody reagents for protein function analysis.![]()
On April 21, 1998, established Kumamoto Antibody Laboratory Inc. with capital of 11 million yen in Egoshi, Kumamoto City, for the purpose of developing, manufacturing, and selling antibodies as reagents for protein function analysis.![]()
In April 2000, opened Tokyo Sales Office (Tokyo Office). Relocated headquarters to Kuhonji, Kumamoto City. Transferred the rights to the “Gene Trap Method Using Trap Vectors” from the Kumamoto Techno Poliss Foundation (now Public Interest Incorporated Foundation Kumamoto Industry Support Foundation), and started the gene knockout mouse business, changing the company name to Transgenic Inc.![]()
Received transfer of 'Gene Trap Vector and Gene Trap Method Using It' from Kumamoto Techno Poliss Foundation (now Public Interest Incorporated Foundation Kumamoto Industry Support Foundation), and started gene knockout mouse business, changing the trade name to Transgenic Corporation.![]()
In December 2001, signed a sales agreement for gene knockout mouse sequence information with Yakult Honsha Co., Ltd. (now Astellas Pharma Inc.) and Sumitomo Chemical Co., Ltd.![]()
Entered into a sales agreement for gene knockout mouse sequence information with Yamauchi Pharmaceutical Co., Ltd. (now Astellas Pharma Inc.).![]()
Entered into a sales agreement for gene knockout mouse sequence information with Sumitomo Chemical Co., Ltd. (now Sumitomo Chemical Co., Ltd.).![]()
Entered into a sales agreement for gene knockout mouse sequence information with Yamanochi Pharmaceutical Co., Ltd. (now Astellas Pharma Inc.).![]()
Entered into a sales agreement for gene knockout mouse sequence information with Sumitomo Chemical Co., Ltd. (now Sumitomo Chemical Co., Ltd.).![]()
In May 2006, acquired shares of Primeum Corporation (now a consolidated subsidiary) and made it a subsidiary.![]()
In April 2013, established Shinyaku Research Center Inc. (now a consolidated subsidiary). Transferred business from Shinyaku Development Laboratory to Shinyaku Research Center Inc.![]()
Established New Drug Research Center Corporation (now a consolidated subsidiary). Transferred business from New Drug Development Laboratory Corporation.![]()
Transferred business from Shin-Yaku Development Research Institute to Shin-Yaku Research Center Co., Ltd.![]()
In July 2013, acquired shares of Medifom Inc. (now a consolidated subsidiary) and made it a subsidiary. Made Genetic Lab Inc. (now a consolidated subsidiary) a subsidiary through third-party allotment of shares.![]()
Made Genetic Lab Corporation (now a consolidated subsidiary) a subsidiary through third-party allotment of new shares.![]()
Made Genetic Laboratory Inc. (currently a consolidated subsidiary) a subsidiary through third-party allotment of new shares.![]()
In July 2015, made Medical Chemistry Drug Discovery Inc. (now a consolidated subsidiary) a related company through third-party allotment of shares. Moved headquarters to Chuo Ward, Fukuoka City.![]()
Made Pharmaceutical Chemistry Drug Discovery Corporation (now a consolidated subsidiary) a related company through third-party allotment of new shares.![]()
Made Medical Chemistry Drug Discovery Inc. (currently a consolidated subsidiary) an affiliated company through third-party allotment of new shares.![]()
In November 2017, established TG Business Service Inc. (now a consolidated subsidiary). Acquired shares of Lopexx Japan Inc. (now a consolidated subsidiary) and made it a subsidiary.![]()
In February 2018, acquired shares of Outlet Plaza Inc. (now a consolidated subsidiary) and made it a subsidiary.![]()
Made Outlet Plaza Inc. (currently a consolidated subsidiary) a subsidiary through share acquisition.![]()
April 2018: Acquired business from Food, Agriculture, Medical and Pharmaceutical Safety Evaluation Center, a public interest incorporated foundation, at Anpo Center Inc.![]()
Transferred business from the Food, Agriculture, Medical and Pharmaceutical Safety Evaluation Center, a public interest incorporated foundation, to Yasuhyo Center Corporation.![]()
Transferred business from the Food, Agriculture, Medical, and Pharmaceutical Safety Evaluation Center, a public interest incorporated foundation, to Yasuhyo Center Inc.![]()
March 2020: Made Galax Trade Inc. (now a consolidated subsidiary) a subsidiary through share acquisition.![]()
Made Garlax Trading Inc. (currently a consolidated subsidiary) a subsidiary through share acquisition.![]()
January 2022: Transferred all shares of Genetick Lab Inc. to Eurofins Clinical Testing Japan Holding Inc.![]()
Transferred all shares of Genetic Lab Corporation to Eurofins Clinical Testing Japan Holding Corporation.![]()
April 2022: Changed from the Mothers Market to the Growth Market on the Tokyo Stock Exchange following a review of market classification.![]()
Due to the review of market classification by the Tokyo Stock Exchange, transitioned from the Mothers Market to the Growth Market.![]()
Changed from the Tokyo Stock Exchange Mothers Market to the Growth Market due to a review of market classification.![]()
September 2022: Made Tomei Shokai Inc. (now a consolidated subsidiary) a subsidiary through share acquisition.![]()
Made Tomen Trading Inc. (currently a consolidated subsidiary) a subsidiary through share acquisition.![]()
October 2024: Merged New Drug Research Center Inc. and Anpo Center Inc. through absorption-type merger with New Drug Research Center Inc. as the surviving company, and changed the trade name to Transgenic Inc., then to Transgenic Group Inc.![]()
Merged with Shin-Yaku Research Center Co., Ltd. and Shin-Yaku Center Co., Ltd. using an absorption-type merger with Shin-Yaku Research Center Co., Ltd. as the surviving company, and changed the trade name to Transgenic Corporation. Changed the trade name to Transgenic Group Corporation.![]()
News
There is no news.
Public records
National Tax Agency basic information9330001006698
- Trade name
- 株式会社トランスジェニックグループ
- Trade name (kana)
- トランスジェニックグループ
- Name in English
- Corporation type
- 301
- Address
- 〒810-0001 福岡県福岡市中央区天神2丁目3番36号
- Postal code
- 8100001
- Prefecture code
- 40
- City code
- 133
- Address outside Japan
- Prefecture in English
- City in English
- Address outside Japan in English
- Corporate number assignment date
- 2015-10-05
- Update date
- 2024-10-15
- Change date
- 2024-10-01
- Registry closure date
- Reason for registry closure
- Successor corporate number
- Details of the change
- Latest record
- 1
- Excluded from search
- 0
- Processing type
- 11
- Correction type
- 0
- Trade name image ID
- Address image ID
- Sequence number
- 5373720
METI gBizINFO9330001006698
- Corporate number
- 9330001006698
- Trade name
- 株式会社トランスジェニックグループ
- Trade name (kana)
- トランスジェニックグループ
- Trade name (alphabet)
- Registry closure date
- Reason for registry closure
- Registered address
- 福岡県福岡市中央区天神2丁目3番36号
- Postal code
- 8100001
- Prefecture
- 福岡県
- Prefecture code
- 40
- City or district
- 福岡市中央区
- City code
- 133
- Street address
- 天神2丁目3番36号
- Organisation type
- 301
- Processing type
- 11
- Correction type
- 0
- Status
- Representative
- 代表取締役社長 福永 健司
- Capital
- 50000000
- Employees
- 6
- Employees (male)
- Employees (female)
- Business summary
- Website URL
- Year founded
- Business category
- Date established
- Unified government qualification - grade
- Unified government qualification - business items
- Update date
- 2024-10-15
- Key information
- 9330001006698